发明名称 |
USE OF C-MET PROTEIN FOR PREDICTING THE EFFICACY OF ANTI-HEPATOCYTE GROWTH FACTOR (HGF) ANTIBODIES IN ESOPHAGEAL AND GASTRIC CANCER PATIENTS. |
摘要 |
<p>The present invention relates to use of the human Met receptor (also known as "c-Met") for predicting the efficacy of inhibitors of the HGF-Met pathway, and in particular, anti-HGF antibodies, in the treatment of esophageal and gastric cancer patients. The present invention also relates to methods and kits for predicting the usefulness of anti-HGF antibodies in the treatment of esophageal and gastric cancer.</p> |
申请公布号 |
MX2014002762(A) |
申请公布日期 |
2014.07.30 |
申请号 |
MX20140002762 |
申请日期 |
2012.09.07 |
申请人 |
AMGEN INC. |
发明人 |
ABRAHAM ANDERSON;KELLY OLINER;RUI TANG;ELWYN LOH;SARITA DUBEY |
分类号 |
A61K39/395;G01N33/574;G01N33/68 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|